Carrier Detection of Haemophilia B by Using an Intragenic Restriction-Fragment Length Polymorphism

Summary

We analysed DNA from individuals of five families with haemophilia B, including nineteen potential carriers. A genespecific probe was used to reveal a TaqI restriction-fragment length polymorphism. Segregation analysis of the polymorphic marker and the deleterious mutation within families allowed diagnosis at the gene level for 16 out of the 19 potential carriers, two proving to be carriers and 14 non-carriers. The obvious advantage is that lyonisation, which is a limiting factor when gene product (clotting factor IX) measurements are used for carrier detection, does not interfere with this procedure and that the result is a definitive diagnosis instead of a risk estimate. The method also permits prenatal diagnosis on chorionic villi in the first trimester of pregnancy.

Restriction-fragment length analysis, based upon the probe and restriction enzyme used in this study, will be informative for approximately 45% of the individuals at risk of carrying or transmitting the haemophilia B mutation.

Keywords

Carrier detection - Haemophilia B - Restriction-fragment length polymorphism

• References

• 1 Akhmeteli MA, Aledort LN, Alexaniants S. Methods for the detection of haemophilia carriers: a memorandum. Bull WHO 1977; 55: 675-702
• 2 Graham JB. Genotype assignment (carrier detection) in the haemophilias. Clin Haematol 1979; 8: 115-145
• 3 Briët E, Van Tilburg NH, Veltkamp JJ. Oral contraception and the detection of carriers in haemophilia B. Throm Res 1978; 13: 379-388
• 4 Ørstavik KH, Veltkamp JJ, Bertina RM, Hermans J. Detection of carriers of haemophilia B. Br. J Haematol 1979; 42: 293-301
• 5 Lyon MF. Gene action in the X-chromosome of the mouse (mus musculus L.). Nature 1961; 190: 372-373
• 6 Choo KH, Gould KG, Rees DJG, Brownlee GG. Molecular cloning of the gene for human anti-haemophilic factor IX. Nature 1982; 229: 178-180
• 7 Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX (cDNA hybridization/DNA sequence analysis/blood coagulation). Proc Natl Acad Sci 1982; 79: 6461-6464
• 8 Jaye M, De la Salle H, Schamber F, Balland A, Kohli V, Findeli A, Tolstoshev P, Lecocq J-P. Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucleic Acids Res 1983; 11: 2325-2335
• 9 Giannelli F, Choo KH, Rees DJG, Boyd Y, Rizza CR, Brownlee GG. Gene deletions in patients with haemophilia B and anti-factor IX antibodies. Nature 1983; 303: 181-182
• 10 Peake IR, Furlong BL, Bloom AL. Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency). Lancet 1984; 2: 242-243
• 11 Bertina RM, Veltkamp JJ. The abnormal factor IX of Hemophilia B⁺ variants. Thromb Haemostas 1978; 40: 335-349
• 12 Giannelli F, Choo KH, Winship PR, Rizza CR, Anson DS, Rees D JG, Ferrari N, Brownlee GG. Characterisation and use of an intragenic polymorphic marker for detection of carriers of haemophilia B (factor IX deficiency). Lancet 1984; 2: 239-241
• 13 Grunebaum L, Cazenave J-P, Camerino G, Kloepfer C, Mandel J-L, Tolstoshev P, Jaye M, De la Salle H, Lecocq J-P. Carrier detection of hemophilia B by using a restriction site polymorphism associated with the coagulation factor IX gene. J Clin Invest 1984; 73: 1491-1495
• 14 Veltkamp JJ, Drion EF, Loeliger EA. Detection of the carrier state in hereditary coagulation disorders. I. Thromb Diathes Haemorrh 1968; 19: 279-303
• 15 Bertina RM, van der Linden IK. Inhibitor-neutralisation assay and electro-immuno assay of human factor IX (Christmas factor). Clin Chim Acta 1977; 77: 275-286
• 16 Weening RS, Roos D, Loos JA. Oxygen consumption of phagocytising cells in human leucocyte and granulocyte preparations: a comparative study. J Lab Clin Med 1974; 83: 570-576
• 17 Baas F, Bikker H, Van Ommen G-JB, De Vijlder JJM. Unusual scarcity of restriction sites in the human thyroglobulin gene. A linkage study suggesting autosomal dominance of a defective thyroglobulin allele. Hum Genet 1984; 67: 301-305
• 18 Hofker MH, Wapenaar MC, Goor N, Bakker B, Van Ommen G-JB, Pearson PL. Isolation of probes detecting restriction fragment length polymorphisms from X chromosome specific libraries: Potential use for diagnosis of Duchenne muscular dystrophy. Hum Genet. 1985 in press
• 19 Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbour. 1982
• 20 Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517
• 21 Bertina RM, Van der Linden IK. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight. J Lab Clin Med 1982; 100: 695-704
• 22 Bertina RM, Veltkamp JJ. A genetic variant of factor IX with decreased capacity for Ca²⁺ binding. Br J Haematol 1979; 42: 623-635
• 23 Graham JB, Barrow ES, Elston RC. Discussion paper: Lyonization in hemophilia: a cause of error in direct detection of heterozygous carriers. Ann NY Acad Sci 1975; 240: 141-146
• 24 Winship PR, Anson DS, Rizza CR, Brownlee GG. Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucleic Acids Res 1984; 12: 8861-8872
• 25 Mibashan RS, Rodeck CH, Thumpston JK. Prenatal diagnosis of the hemophilias. In: Methods in Hematology; The Hemophilias. Bloom AL. (Ed) Churchill Livingstone; Edinburgh: 176-196
• 26 Kazy Z, Rozovsky S, Bakharev VA. Chorion biopsy in early pregnancy.A method of early prenatal diagnosis for inherited disorders. Prenatal Diagn 1982; 2: 39-45